Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05565781 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke

Study acronym: SMARTTHUNDER
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 4, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Sep 1, 2024 to Jun 1, 2025
    • Secondary endpoints: details revised at 1 of 5 entries
    v3
  2. Primary completion date: Apr 1, 2023 to Sep 1, 2024
    • Study completion date: Apr 1, 2024 to Sep 1, 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stroke recurrence largely depends on the detection of the cause and the control of vascular risk factors, with occult atrial fibrillation (AF) being one of the most important. Prolonged ambulatory cardiac monitoring is recommended for detecting occult AF. Currently, there are non-invasive monitoring devices such as the textile Holter that have proven to be useful for monitoring for up to 30 days but not longer. Another alternative is smartwatches, although they must be validated for use in the elderly population who have had a stroke.
Trial Details
NCT Number NCT05565781
Lead Sponsor Hospital Universitari Vall d'Hebron Research Institute
Conditions
(from sponsor)		 Paroxysmal Atrial Fibrillation, Cryptogenic Stroke
Related terms Atrial Fibrillation, Ischemic Stroke
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov